These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7739846)

  • 41. Immunocytochemical analysis of hormone receptors with malignant cells separated from human mammary tumors.
    Gaffney EV; Halpin DP; Moody WE; Elliott CB
    Am J Clin Pathol; 1994 Jul; 102(1):68-71. PubMed ID: 8037169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: evaluation of discordant findings.
    Stierer M; Rosen H; Weber R; Hanak H; Auerbach L; Spona J; Tüchler H
    Breast Cancer Res Treat; 1998 Jul; 50(2):125-34. PubMed ID: 9822217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogen and progesterone receptors in breast cancer microsamples simultaneously quantified by enzyme-ligand immunoassay.
    Krambovitis E; Hatzidakis G; Hatzoglou A; Romain S; Durand A; Stefanakis A; Castanas E
    Clin Chem; 1995 Jan; 41(1):48-53. PubMed ID: 7813080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between low estrogen receptor values and other prognostic factors in primary breast tumors.
    Gaffney EV; Halpin DP; Blakemore WS
    Surgery; 1995 Mar; 117(3):241-6. PubMed ID: 7878527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen and progesterone receptors in human meningiomas: biochemical and immunocytochemical evaluation.
    Bozzetti C; Camisa R; Nizzoli R; Manotti L; Guazzi A; Naldi N; Mazza S; Nizzoli V; Cocconi G
    Surg Neurol; 1995 Mar; 43(3):230-3; discussion 234. PubMed ID: 7792684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Micronutrient intake and breast cancer characteristics among postmenopausal women.
    Roswall N; Olsen A; Christensen J; Dragsted LO; Overvad K; Tjønneland A
    Eur J Cancer Prev; 2010 Sep; 19(5):360-5. PubMed ID: 20698054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.
    Domanski AM; Monsef N; Domanski HA; Grabau D; Fernö M
    Cytopathology; 2013 Feb; 24(1):21-5. PubMed ID: 22783929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Analysis of steroid hormone receptors in endometrial cancer].
    Kedzia W
    Ginekol Pol; 1996 May; 67(5):254-8. PubMed ID: 8925997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
    Oyaizu T; Arita S; Hatano T; Tsubura A
    J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
    Schenck U; Jütting U; Eiermann W
    Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.
    Chapman JW; Bayani J; SenGupta S; Bartlett JMS; Piper T; Quintayo MA; Virk S; Goss PE; Ingle JN; Ellis MJ; Sledge GW; Budd GT; Rabaglio M; Ansari RH; Tozer R; D'Souza DP; Chalchal H; Spadafora S; Stearns V; Perez EA; Gelmon KA; Whelan TJ; Elliott C; Shepherd LE; Chen BE; Taylor KJ
    J Clin Oncol; 2024 Aug; 42(24):2887-2898. PubMed ID: 38824432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.
    Arpino G; Weiss HL; Clark GM; Hilsenbeck SG; Osborne CK
    J Clin Oncol; 2005 Jul; 23(21):4687-94. PubMed ID: 15837971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Dell'Orto P; Rasmussen BB; Raffoul J; Neven P; Orosz Z; Braye S; Ohlschlegel C; Thürlimann B; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2007 Sep; 25(25):3846-52. PubMed ID: 17679725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer.
    Detre S; King N; Salter J; MacLennan K; McKinna JA; Dowsett M
    J Clin Pathol; 1994 Mar; 47(3):240-4. PubMed ID: 8163696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progesterone receptor determination in human breast tumors by immunocytochemical and biochemical techniques.
    Cappelletti V; Patriarca C; Granata G; Cattoretti G; Coradini D; Di Fronzo G; Horwitz K
    Breast Cancer Res Treat; 1989 Nov; 14(2):217-25. PubMed ID: 2690973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of tamoxifen on the tumor content of steroid hormone receptors (ER, PgR and AR) in patients with primary breast cancer.
    Lundgren S; Søreide JA; Lea OA
    Anticancer Res; 1994; 14(3B):1313-6. PubMed ID: 8067700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An investigation of cut-points for primary breast cancer oestrogen and progesterone receptor assays.
    Chapman JW; Mobbs BG; McCready DR; Lickley HL; Trudeau ME; Hanna W; Kahn HJ; Sawka CA; Fish EB; Pritchard KI
    J Steroid Biochem Mol Biol; 1996 Mar; 57(5-6):323-8. PubMed ID: 8639468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group.
    Bernoux A; de Cremoux P; Lainé-Bidron C; Martin EC; Asselain B; Magdelénat H
    Breast Cancer Res Treat; 1998 Jun; 49(3):219-25. PubMed ID: 9776505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expression of steroid receptors and DNA synthesis in male breast cancer].
    Petroni S; Mangia A; D'Amico C; Simone G
    Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.
    Yu KD; Liu GY; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM
    Breast; 2007 Jun; 16(3):307-15. PubMed ID: 17293115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.